17.200
−0,58%
2026-10-16
Fundamental Analysis
22 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -50.9% | -61.6% | 1 / 3 | +21.4% | -1.50 pp | -0.92 pp | +4.2% | 1.98 | 30.94 | 742 | +21,4% | 4,6 | −50,9% | 30.94 | 16.94 | +82,6% |
| Pts | 0 | 0 | 4 | 12 | 4 | 4 | 0 | -4 | 4 | |||||||
Valuation annotation:Price: 17.200 (close price on 2026-10-16)EPS (TTM): 555,9
Financial charts
1.Revenue & growth
VND bn742Q2/26
1.Revenue & growth
VND bn742Q2/26
2.Profit & growth
VND bn4,28Q2/26
3.Profit mix (Penman)
VND bn51,1Q2/26
4.Margins & cost structure
%6.8%Q2/26
5.Returns & cash cycle
% · days2.6%Q2/26
6.Earnings quality & cash
VND bn-327Q2/26
7.Asset structure
VND bn2.060Q2/26
8.Funding & debt health
VND bn · times2.060Q2/26
9.Revenue backlog
VND bn13,2Q2/26
10.Valuation
times · %30,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %98Q2/26
Adjusted EPS growth, latest quarter
-50.9%
Average adjusted EPS growth, 3 quarters
-61.6%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26